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Abstract 
Chronic obstructive pulmonary disease (COPD) is a common life-limiting illness with 
significant burden for patient and carer. Despite this, access to supportive and specialist 
palliative care is inconsistent and implementation of published good practice 
recommendations may be challenging within current resources. The aim of this service 
development was to improve local service provision in Barnsley, within the currently available 
resources, for patients with very severe COPD, to improve patient identification and symptom 
management, increase advance care planning and the numbers of patients dying in their 
preferred place, and increase patient and carer support and satisfaction. To do this a working 
group was formed, the service problems identified and baseline data collected to identify the 
needs of people with very severe COPD. A multidisciplinary team (MDT) meeting was piloted 
and assessed by community matron feedback, patient case studies and an after death 
analysis (ADA). These indicated a high level of satisfaction, with improvements in advance 
care planning, co-ordination of management and support for patients’ preferred place of care 
at the end of life. In conclusion this is the first reported very severe COPD service 
development established in this way and within current resources. Preliminary data indicates 
the development of the MDT meeting has been positive. The appointment of a coordinator will 
aid this development. Further evaluations particularly seeking patient views and estimations of 
cost savings will be performed. 
                         
 
Background   
Over 25,000 people die each year in the United Kingdom from chronic obstructive pulmonary 
disease (COPD). Patients with COPD often have limited access to palliative care including at 
the end of life despite having a similar prognosis and symptom burden to lung cancer.(1-4) 
Furthermore, both studies and guidelines have emphasised the need for collaborative working 
across primary and secondary care with multidisciplinary teams (MDTs) to provide improved 
access to services and support to patients with COPD at the end of their lives.(1, 2, 5, 6) 
However, there is a need for significant service improvement to improve Advance Care 
Planning (ACP) in patients with COPD before this goal of the End of Life Care Strategy can be 
achieved.(4, 7) However, service improvements can be challenging in the context of restricted 
budgets and historical patterns of practice. 
In Barnsley, a former mining town in northern England, 16.4% of deaths in 2008-2010 were 
from respiratory disease(8) and a high percentage of these patients die in acute care, often 
with little or no palliative care input (Table 1). Patients in Barnsley with COPD have been 
shown to consider dyspnoea as a normal part of life and due to the way they view this, could 
be more effectively engaged by clinicians.(9) We therefore aimed to improve the quality of 
palliative care provided to patients with very severe COPD by introducing a MDT approach to 
improve their identification and management. This need for such an approach has been 
described and this is a report of how a service has implemented the recommendations in 
practice.(1, 2, 5, 6) This is, to our knowledge, the first report of such a service to have been 
developed in this way within current resources. 
 
Box A: The key objectives of this service development were to: 
Improve identification of patients with very severe COPD with palliative care needs  
Increase the number of ACP documents completed 
Increase numbers of people dying in their preferred place 
Reduce inappropriate hospital admissions and outpatient appointments 
Ensure patients are able to access timely and effective symptom management 
Share learning across MDT members and opportunities for professional 
development 
Improve equity of access to services 
Increase patient and carer support and satisfaction 
                         
 
Getting started 
 
Establishment of the working group  
A working group (WG) was established, consisting of a respiratory consultant, palliative 
medicine consultant, community matron, respiratory specialist nurse, general practitioner 
(GP), lead nurse, divisional service manager, business unit manager, team leader rapid 
response team, acute care case manager, occupational therapist, end of life care clinical lead, 
commissioners and Marie Curie Delivering Choice Programme advisor. The WG’s remit was 
to assess the problems with the management of patients with very severe COPD and agree 
the management strategies to address them that could be immediately implemented (Box A). 
In view of the MDT model seen in other disease management strategies, the first agreed goal 
was to set up and evaluate the effect of a palliative care/respiratory MDT. The WG  
• Defined the patient population and agreed eligibility criteria for referral to the proposed 
palliative care/respiratory MDT 
• Defined the care pathway 
• Developed the supporting documentation 
• Defined the MDT members 
• Mapped and identified baseline gaps in provision for patients with very severe COPD 
As this was a service development and evaluation project, NHS research ethical committee 
approval was not required for this service development in accordance to NRES guidance. 
 
Patient population and eligibility criteria 
A care pathway (appendix 1), referral criteria (Box B) and supporting documentation (appendix 
2 and 3) for very severe COPD were developed by the WG, based upon the 2011 NICE 
quality standards and Gold Standard Framework prognostic indicator guidance.(10, 11) 
 
 
 
                         
 
Box B: Eligibility for referral to the very severe COPD MDT; at least two of the following were 
needed:(11) 
Severe airflow obstruction (FEV1 <30%) 
Respiratory failure 
BMI <19 
Housebound (MRC dyspnoea score 5) 
History of 2 or more exacerbations during the previous year – either COPD or heart failure 
Need for non-invasive ventilation 
Eligibility for long term home oxygen 
 
 
Initiation of the MDT meeting 
A fortnightly MDT meeting was established to plan management for new referrals and monitor 
those known to the service. A pilot commenced in November 2011 for 6 months, with cases 
presented by the community matrons (key worker). A management plan, including palliative 
care, was formulated for the patient, documented in the patients’ notes and sent to the GP. 
The MDT was chaired by the consultant respiratory physician, and attended by the palliative 
medicine consultant, consultant microbiologist, community matrons, respiratory nurse 
specialist, ward lead nurse, case manager and the community occupational therapist.  
 
Baseline data collection 
Baseline data included patient satisfaction questionnaires and after death analysis (ADA) of 
randomly chosen patients known to the community matron who had died within the previous 3 
months [by JO and RA]. These fed into the WG discussions, to inform the development of the 
service. Patient satisfaction questionnaires asking about satisfaction and palliative care needs, 
designed by the Marie Curie Delivering Choice programme and adapted by the WG, were 
distributed by the community matron team to current patients on their caseloads who met the 
criteria for referral to the MDT. The Gold Standard Framework ADA audit,(12) adapted by 
Marie Curie Delivering Choice Programme, was used [by JO and RA] to evaluate the care of 
patients who had died from COPD from four of the community matron caseloads in the 
previous 6 months.  
                         
 
Evaluation 
At the end of the service development pilot, patient satisfaction questionnaires, and ADAs [by 
JO] were repeated and compared with baseline. The post-pilot patient satisfaction 
questionnaires were distributed by the community matron team to patients whose care had 
been influenced by the MDT and were still alive. ADAs were from patients who had died after 
MDT input. Case studies from patients who were still alive and discussed at the MDT, were 
presented by the community matrons. Community matron feedback consisting of 
questionnaires and a simple structured group feedback [facilitated by JO], explored the 
benefits and problems of the service development on themselves, patients and carers. The 
responses of these were recorded and key issues established.  
Evaluation was planned and coordinated by the WG to identify key issues and further 
questions. The ADA, questionnaire, case history and feedback group data was collated, 
analysed and key issues and findings were identified. These were discussed with the WG to 
identify further questions and make recommendations for future service provision and 
planning, before re-evaluation. Progress was reported through the organisation’s own 
governance structures and to the End of Life Care Operational and Strategy Group.  As part of 
the monitoring and evaluation process, the MDT continuously explored improving the 
development and work to ensure that any unmet needs were identified and brought to the 
attention of the WG. 
 
                         
 
Results  
Pre-pilot baseline data 
The common issues seen from the patient satisfaction questionnaires and ADA and the key 
problems in service provision identified by the WG are summarised in Box C. 
 
Patient questionnaire data 
Anonymous data was collated from 16 returned patient satisfaction questionnaires (response 
rate = 80%). Care was generally rated as excellent/very good, however, 7/16 (44%) patients 
reported that they were not always involved in decisions about their care, 4/16 (25%) said they 
were not always able to talk to professionals about things that mattered to them, 3/16 (19%) 
reported family support as poor/fair and 2/16 (13%) were not satisfied with the emotional 
support. Just under half (7/16; 44%) reported that they did not feel the team caring for them 
always communicated appropriately about their care.  In the previous year 7/16 (44%) had 2 
or more admissions and 5/16 (31%) patients had seen their GP more than 3 times about their 
COPD. None of the returned questionnaires reported specialist palliative care involvement. 
 
ADA data 
The ADA was completed on 5 patient records and highlighted that 4/5 (80%) had a `do not 
attempt cardiopulmonary resuscitation` (DNACPR) and pre-emptive prescribing in place, 1/5 
(20%) had documented evidence of ACP and holistic assessment. Patients had an average of 
five admissions in the previous year, 3/5 (60%) had had more than 10 crisis admissions and 
an average of 26 days was spent in hospital in the year before death. Documentation about a 
MDT plan was only present in one case, enabling team working and this patient to die at 
home, her preferred place. No patient had a referral to or involvement from specialist palliative 
care. There was no documentation around bereavement care in any of the cases.  
 
 
 
 
                         
 
Box C: Key issues highlighted from the WG, patient satisfaction questionnaires and ADA 
Need for increased holistic individualised assessment 
Need to decrease admissions in the end stages of disease 
Need for a more coordinated approach with a clear management plan 
Need for increased specialist palliative care involvement 
Need for education and support for community matron team  
 
 
Post-pilot evaluation 
Twenty-one patients were referred for discussion at the MDT between 30 November and 9th 
May. The community matrons also contacted the respiratory and palliative medicine teams 
between MDTs to provide responsive management of patients. Following MDT discussions, 
palliative medicine consultations occurred in acute, hospice and domiciliary settings. The 
relatively small numbers of patients discussed allowed for in-depth discussion and teaching, 
which the community matrons reported improved their ability to care for other patients, 
decreasing the need for individual discussion at the MDT for some patients. This was in part 
responsible for the low referral rate to the MDT, despite the relatively broad referral criteria 
(Box B). The number of patients dying from COPD on the last days of life care pathway in the 
community increased from 1/49 (2%), in the corresponding 6 months in the previous year, to 
4/53 (8%) in this 6 month pilot. Although small numbers it may reflect an increasing 
awareness, confidence and proactive care.  
 
Patient satisfaction questionnaires and case studies 
There was a poor response rate from the patient satisfaction questionnaires (4/20) so instead 
five case studies (a summarised example can be seen in Box D) and an ADA on eight patients 
were used. Most (8/10) professional questionnaires were returned and a structured group 
feedback session with seven community matrons was held. The main areas of reported 
improvement are summarised in Box E. 
 
 
 
                         
 
Box D: An illustrative case history. 
Mr P is a 59 year old with COPD, alcohol dependence, malnutrition and weight loss. The 
community matron discussed this patient at the MDT as he was not included on the palliative 
care register as despite his advanced and life-limiting illnesses as his GP said “he didn’t have 
cancer”. The MDT agreed that he was likely in the last year of life and as a result he received 
appropriate clinical management and ACP, as well as increased social support and access to 
benefits.  
 
 
Review of the case studies illustrated that improvements in quality of life and symptom control 
and a reduction in the number of hospital admissions can be made with simple measures: 
using a patient-centred approach, education and discussions around prognosis, and the 
optimisation of symptoms by both non-pharmacological and pharmacological means. For 
example, the use of relaxation techniques, a hand-held fan, and a trial of palliative oxygen, if 
hypoxaemic, provided symptom relief for some patients. Furthermore, by using careful titration 
of low dose opioids and appropriate use of benzodiazepines for dyspnoea and anxiety, 
activities of daily living and quality of life can be improved.  
 
Community matron questionnaire data and structured group feedback  
All preferred the new ways of working, felt they were supported better with improved access to 
the respiratory and palliative medicine consultants to manage symptoms and end of life care, 
and felt that the needs of the patient and family were met more fully. All were very 
satisfied/satisfied with the MDT, documentation and COPD pathway. All reported the input 
from the consultant in palliative medicine resulted in an improvement in patient experience and 
6/8 (75%) reported better confidence in symptom management. They reported clear 
management plans following discussion at the MDT with patients subsequently being 
discussed at the GP led palliative care meetings with better coordination of care. They felt 
there was earlier recognition of end of life allowing holistic needs to be met and improving 
quality of life, although they said that patients and their families found ACP discussions difficult 
                         
 
and often did not want to complete a preferred priorities for care document. There was a 
perception that the MDT reduced admissions, highlighting a patient whose hospital admissions 
were reduced from up to 3 times per week to 3 times in 2 months and another who had 6 
admissions in the year before MDT planning, in the 6 months after which she none.  
 
 
ADA data 
The ADA was completed on eight patient records. All demonstrated involvement from 
specialist palliative care. Of the 6/8 (75%) who specified a preferred place of death, five (83%) 
patients achieved this due to proactive planning. Bereavement follow-up occurred in 7/8 (88%) 
cases. There was documented evidence of a coordinated case management approach and/or 
discussion at the GP palliative care meetings in 7/8 (88%) cases. For the patients dying at 
home or care home 4/5 (80%) had a DNACPR, 2/5 40%) were on a last days of life care 
pathway, 4/5 (80%) had anticipatory prescribing and 4/5 (80%) had evidence of 
communication with out of hours GPs. Although ACP was offered to 7/8 (88%) patients, only 
2/7 (29%) wanted to complete a preferred priorities for care document. The ADA showed an 
average number of 13 bed days in the 6 months prior to death, with 1 patient accounting for 
over 50% of this. There was an average of 1.9 admissions per patient in these 6 months. 
Nearly two thirds (5/8; 63%) of patients died at home or in a care home.  
 
Box E: Key benefits of the service development highlighted from the professional 
questionnaires and structured feedback sessions, case studies and ADA 
Service development activity levels and associated outcomes 
Improved access to specialist palliative care support 
Recognition of end of life care needs 
Improved coordination 
Reduction in unnecessary hospital admissions 
Support and shared learning 
 
 
 
                         
 
Discussion 
We report here our local initiative to put national guidelines(6, 11) into clinical practice within 
resources for patients with very severe COPD. Although service models have been previously 
described,(13) this is, to our knowledge, the first reported to have been developed in this way 
within current resources. It has promoted the combination of a palliative care approach to the 
traditional disease-directed therapy with the introduction of an MDT meeting. As community 
matrons deliver the majority of care to these patients, often without specialist input, the MDT 
offered a route of support, from both the respiratory and palliative medicine physicians. The 
accessibility of these physicians for support and advice has been one of the key benefits from 
this pilot. The outcomes so far have indicated benefits both to the community matrons and to 
patients, particularly in terms of symptom management and quality of life. End of life 
recognition and planning was more evident with more patients dying in their preferred place (at 
home/care home) with appropriate plans in place in contrast to published work indicating that 
recognising the transition to palliative care in COPD can be difficult. Bereavement support had 
also increased. During the pilot there was an increase in the number of patients who had 
specialist palliative care input. With the small numbers and limited time it is difficult to draw 
conclusions about admissions, but with the exception of 1 patient who accounted for over 50% 
of the bed days, admissions seemed to be fewer. This might be due to a combination of 
pharmacological optimisation (both disease and symptom directed), an action plan being 
devised, with consultant backup, resulting in increased confidence of the community matrons 
and patients, thereby potentially decreasing emergency, anxiety related, admissions. Although 
we did not get a large change in outcomes, which could be due to the small sample size and 
limited time-frame, those seen were not inconsiderable and were important to patients and the 
clinical staff, necessitating continuation of the service development and its further evaluation.  
Patients with very severe COPD have a large symptom burden and a limited prognosis, yet do 
not have consistent access to specialist palliative care or have their end of life care needs 
identified and addressed. By delivering palliative management alongside continuing optimally 
tolerated disease modifying therapy, symptom control and quality of life can be maximised. 
The same is also true of other non-malignant respiratory diseases, and patients with these 
                         
 
were also occasionally discussed at the MDT, thus a future option would be to include these 
illnesses and expand the meeting into a more encompassing chronic respiratory MDT. 
Although prognostication can be difficult in very severe COPD, there is a crucial need for good 
palliative care, communication including discussions around future care,(4, 14) as this group of 
patients want to more involved in decisions about their treatment, however they are more 
comfortable discussing their general views and probable preferences about future care, rather 
than forming a binding plan.(5) 
 
Prior to the MDT, although there were many professionals involved, there was often no 
consistent management plan, poor communication and a lack of identification of palliative care 
need. The community matrons reported that some GPs remained reluctant to discuss patients 
with very severe COPD at their palliative care MDTs as there was not a clear prognosis, 
despite national guidance.(10, 11)  
 
This service development incorporates all the components of the Chronic Care Model systems 
of care.(15) Patients are encouraged to self-manage as the health care professionals are 
formulating a clear plan and increasing the information and support given to patients. The 
delivery system is primarily non-physician based, with the community matrons being the key 
workers, delivering a responsive, variable intensity service depending on the patients’ needs, 
to pre-empt problems and manage them proactively. This is supported by specialist physicians 
with clinical expertise and experience in the palliative and disease-directed management of 
COPD both within and between MDT meetings. Clinical information systems were utilised, 
both as monitoring of some of these patients used telehealth and if appropriate by their 
inclusion on the GP palliative care register and SystmOne End of Life Care template, to 
coordinate the delivery of planned care. 
   
Given the high satisfaction and preliminary benefits for professionals across the district of 
Barnsley and ultimately patients and their families, the MDT meetings will continue, with the 
aim to identify a co-ordinator, with twice yearly re-evaluation of the benefits and savings 
                         
 
produced by this development. Future work will involve the identification of an MDT co-
ordinator to facilitate the meetings and improve documentation and dissemination of 
outcomes; education sessions and workshops to enhance discussions and the skills of 
community matrons will also be provided. Further work is also needed to improve the 
measurement of patient relevant outcomes and discussion with patients in hospital/clinic 
regarding disease progression. The low rate of end of life discussions with patients by 
clinicians, in our service and elsewhere, remains a challenge in the provision of palliative care 
for those with non-malignant disease.(16) We hope to improve this by encouraging ACP to be 
initiated for patients by secondary care clinicians and then discussing the outcome of these 
with the primary care team. The primary care team are then well placed to continue the 
planning with the patients in the community as well as optimising the Gold Standards 
Framework approach for patients with COPD. Conversations about difficult issues are likely to 
be challenging, but this should not mean they should be avoided or that they are necessarily 
stressful for most, over and above the problems faced by the patient and carer at that stage of 
the illness, when conducted with sensitivity and a careful assessment made to ensure the 
patient is willing to participate.(17) Indeed, many find the opportunity to discuss hopes and 
concerns for future care helpful.(18) However, all too commonly, these discussions in people 
with advanced chronic conditions are avoided by clinicians who may be anxious about “taking 
away hope” and who remain unwilling to discuss future care plans when prognosis remains 
unclear.(4, 16) 
 
Limitations 
As this project was an initial service development pilot funded from within current resources 
numbers of patients are small and the methodology used was simple. There was also poor 
questionnaire return from patients in the post-pilot data. No cost saving assessment was 
performed. However, we do have important positive preliminary data to support further 
development and evaluation of this service. 
 
 
                         
 
Conclusion 
The preliminary data from this service development pilot indicates that the development of an 
MDT meeting and pathway of care for patients with very severe COPD has benefited both 
patients and community matrons, with better recognition of end of life care needs and 
increased number of patent supported in their preference, if applicable, to die  at home/care 
home. The matrons felt more supported in their case management with easier access to 
palliative and respiratory physicians, with a more coordinated approach to care across 
organisation boundaries. To further this work we plan to appoint a coordinator, deliver 
education and continue to monitor this development in a more robust way to confirm patient 
benefit and assess any cost savings. Although our preliminary findings need to be confirmed 
more systematically, we hope our initial experience will encourage other local providers to look 
at reconfiguring their services to encompass patients with very severe COPD. 
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